Neuro QB SRL
Neuro QB reported total assets of 536,018 € at the end of the 2025 financial year (annual accounts filed with the NBB on 28 Aug 2026).
By total assets for 2025, Neuro QB ranks in the top half of the 15,434 companies in its sector (NACE 8622) in Belgium that filed accounts for that financial year. Largest companies in the sector →
The score of Neuro QB shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Accounts of the company itself (not consolidated).
Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Neuro QB's annual accounts
| 2025 | |
|---|---|
| Net result | 87,631 € |
| Equity | 86,898 € |
| Cash | 16,663 € |
| EBITDA | 205,870 € |
| Total assets | 536,018 € |
Filed annual accounts
- Year ended 31 Dec 2025filed on 28 Aug 2026
Neuro QB's financial analysis
- Solvency16.2%sector median: 64.5%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Neuro QB
Neuro QB's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 1014.953.164
- VAT number
- BE1014953164
- Peppol
- Not found on Peppol as of 10 Nov 2026 · Check
- Legal form
- SRL
- Incorporated
- 11 Oct 2024
- Registered office
- 1400 Nivelles
- Latest accounts
- 2025 · filed on 28 Aug 2026
- Activity
- Medical specialists activities (NACE 86220)
Neuro QB (SRL) has been based in Nivelles since 2024, active in: medical specialists activities. For 2025, it reports a net profit of 87,631 € and equity of 86,898 €; its revenue is not published. Its solvency stands at 16.2%, below the median of its sector (64.5%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Neuro QB
Companies in the same business, of comparable size and area, outside its group.
- Zeimers Peter Management Scheduled passenger transport by road Lontzen · balance sheet 535,552 €
- R21B Activities of holding companies Kontich · balance sheet 535,430 €
- Carat Buying and selling of own real estate Knokke-Heist · balance sheet 540,095 €
- VANDOREN Investment Activities of holding companies Keerbergen · balance sheet 536,763 €
- Reynaerts Holding Other financial service activities, except insurance and pension funding n.e.c. Walhain · balance sheet 535,166 €
- JO.LI Activities of holding companies Wuustwezel · balance sheet 535,137 €
- Toumanac Computer consultancy and computer facilities management activities Hamois · balance sheet 537,239 €
- Chasfrog Business and other management consultancy activities Antwerp · balance sheet 534,659 €
Frequently asked questions about Neuro QB
What is the revenue of Neuro QB?
Neuro QB files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Neuro QB?
In Belgium, the VAT number is the company number prefixed with BE: BE1014953164 for Neuro QB, if the company is VAT-registered. Its company number (CBE) is 1014.953.164.
Where is the registered office of Neuro QB?
According to the CBE register, the registered office of Neuro QB is in 1400 Nivelles.
What is the equity of Neuro QB?
At the close of the 2025 financial year, the equity of Neuro QB amounts to 86,898 €, a solvency of 16.2% of total assets.
Who manages Neuro QB?
The register lists 1 active mandates at Neuro QB. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
How large is Neuro QB within its sector?
By total assets for 2025, Neuro QB ranks in the top half of the 15,434 companies in its sector (NACE 8622) in Belgium that filed accounts for that financial year.
The full file of Neuro QB
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →